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Abstract
Multivitamin supplementation has been shown to reduce the risk of low birthweight. This effect could be
mediated through gestational weight gain. However, the effect of multivitamin supplementation on weight gain
during pregnancy has not been fully studied. The objective of this study was to examine the effects of multivi-
tamins on pregnancy weight gain.We enrolled 8468 HIV-negative women from Dar es Salaam, Tanzania, in a
randomised, placebo-controlled trial of multivitamins on birth outcomes. Women were randomly assigned to
receive either a daily oral dose of multivitamin tablets or a placebo and were weighed every 4 weeks from
enrolment until the last visit before delivery. Intent-to-treat analyses were carried out to examine the effects of
multivitamins on pregnancy weight gain. Multivariate linear and binomial regression models with the log-link
function were used to examine the association of weight gain during pregnancy to birthweight.The overall total
weight gain was 253 g (SE: 69, P: 0.0003) more, while the overall 4 weekly weight gain was 59 g greater (SE: 18,
P: 0.005) among women who received multivitamins compared to placebo. Women in the lowest quartile of
gestational weight gain had babies with an average birthweight of 3030 g (SD: 524), while women in the highest
quartile had babies weighing 3246 g (SD: 486), on average. Prenatal multivitamin supplements increased gesta-
tional weight gain, which was a significant predictor of birthweight.
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Introduction
Low birthweight is a major determinant of neonatal
mortality rates,which are still very high globally, espe-
cially in South Asia and sub-Saharan Africa (Ash-
worth 1998; WHO 2006). Inadequate weight gain
during pregnancy is a major risk factor for low birth-
weight (Kramer 1987; Stein et al. 1995; WHO 1997;
Neufeld et al. 1999). Improving maternal nutritional
status before or during pregnancy could help prevent
low birthweight and neonatal deaths in developing
countries.
Evidence on the relationship between macronutri-
ents and prenatal weight gain is evolving. Supplemen-
tation trials during pregnancy in developing countries
have shown that total energy intake increases the
rate of prenatal weight gain (Qureshi et al. 1973;
Lechtig et al. 1975;Tontisirin et al. 1986; Prentice et al.
1987) and that isocaloric protein supplementation
decreases maternal weight gain (Kramer 2000).
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Overall, however, the impact of macronutrient food
supplementation on gestational weight gain appears
to depend on the prior energy deficit, the impact
being greater for those with low pre-pregnancy
weight for height or in those women where food
intake has been restricted (Institute ofMedicine 1990,
2009). The effect of individual micronutrients such as
zinc, iron and folate on pregnancy outcomes including
birthweight has been looked at before (Goldenberg
et al. 1995;Rasmussen 2001; Fall et al. 2003).However,
there are a few studies that have examined the effect
of multiple micronutrients supplementation on preg-
nancy weight gain. In one study among HIV-positive
women inTanzania,we showed that multivitamin sup-
plementation increases pregnancy weight gain (Vil-
lamor et al. 2002). Another study conducted in Chile
showed that women given a daily fortified milk
product had higher weight gain in pregnancy than
women who were given unfortified powdered milk
(Mardones-Santander et al. 1988). Among women in
Mexico, multivitamin supplements did not increase
weight gain during pregnancy after adjusting for base-
line differences in body mass index (BMI; Ram-
akrishnan et al. 2005).
We previously reported that multivitamins
increased birthweight in a randomised trial of HIV-
negative women (Fawzi et al. 2007). In that study, the
incidence of low birthweight was 7.8% among infants
in the multivitamin group and 9.4% among those in
the placebo group [relative risk (RR), 0.82; 95% con-
fidence interval (CI): 0.70, 0.95]. The mean birth-
weight difference between the two groups was 67 g
(P < 0.001). In this paper, we examined the effect of
multivitamin supplements in the same trial on preg-
nancy weight gain, and assessed the relationship of
gestational weight gain to birthweight.
Subjects and methods
Study design and population
We analysed data from 8468 HIV-negative women
who participated in a randomised, double-blind,
placebo-controlled trial in Dar es Salaam, Tanzania.
Women were randomised between August 2001 and
July 2004. The objectives of the trial were to deter-
mine if daily multivitamin supplementation during
the prenatal period would reduce the incidence of
fetal loss, low birthweight (< 2500 g) and preterm
birth (<37 weeks).The details of the study population
for this trial have been described elsewhere (Fawzi
et al. 2007). Consonant with standard prenatal care in
Tanzania, women in both treatment groups also
received daily supplements of 0.25 mg of folic acid,
60 mg of ferrous sulphate and malaria prophylaxis in
the form of sulfadoxine–pyrimethamine tablets.
The participants were screened and recruited from
women who attended antenatal clinics in Dar es
Salaam. The basic eligibility requirements were a
negative test for HIV infection, gestational age
between 12 and 27 weeks according to the date of the
last menstrual period, 18 years of age or older and an
intention to deliver and stay in Dar es Salaam for at
least 1 year after delivery. HIV type 1 serologic status
was ascertained from all the women who consented to
participate in the trial by means of two sequential
enzyme-linked immunosorbent assay tests (Urassa
et al. 1999). All women provided written informed
consent to participate. Women were randomly
assigned to receive either a daily oral dose of multi-
vitamin tablets containing 20 mg of vitamin B1, 20 mg
of vitamin B2, 25 mg of vitamin B6, 100 mg of niacin,
50 mg of vitamin B12, 500 mg of vitamin C, 30 mg of
Key messages
• The effect of multivitamin supplementation on weight gain during pregnancy has not been fully studied
• Multivitamin supplementation during pregnancy appeared to improve gestational weight gain and gestational
weight gain is a predictor of birthweight.
• The effect of multivitamins on birthweight might be mediated through increase in gestational weight gain.
• Further research is required to find the optimal weight gain in mothers in developing countries, and the effects
of intervening earlier in pregnancy on gestational weight and on the risks of adverse pregnancy outcomes.
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vitamin E and 0.8 mg folic acid or a placebo from
enrolment until delivery.
Trained research nurses administered a question-
naire to all the women at enrolment during the
second trimester to collect baseline data on the
woman’s age, partner’s age, maternal education,
marital status, parity, socioeconomic status and other
behavioural and reproductive factors. In addition,
nurses obtained a complete medical and obstetric
history at baseline and performed clinical examina-
tions at baseline and monthly.
Height was measured at baseline using a stadiom-
eter to the nearest 0.1 cm with the subjects without
head covers and shoes. Weight was measured to the
nearest 100 g using balance scales with the women
wearing light clothing without shoes.
Women were encouraged to deliver at Muhimbili
Hospital, where research midwives attended to the
delivery and weighed the infants to the nearest 10 g
on a standard beam balance immediately after birth.
Data analyses
Analyses were limited to women who had a singleton
pregnancy, a known date of pregnancy outcome and
at least two weight measurements from enrolment
through the end of gestation. Data from women with
fetal deaths were not excluded from the analyses.
Compared with 779 women whose data were not
included in this analysis, women who were included
were significantly older, taller, had greater mid upper
arm circumference (MUAC), lower gestational age at
entry and lower haemoglobin. The distribution of the
baseline characteristics was compared across the
treatment groups by using theWilcoxon rank sum and
the Kruskal–Wallis test for continuous variables and
c2 tests for proportions. Intent-to-treat analyses were
carried out to examine treatment effects on weight
gain.
Effect of supplements on gestational weight gain
Changes in weight gain during pregnancy were exam-
ined in two ways: (1) as the total weight change over
the period of follow-up [presented as means and
standard deviations (SDs)]; (2) as 4-week changes in
weight from one visit to the next controlling for the
actual length of the inter-visit interval.
The weight difference between two consecutive
visits (DWEIGHTij) was modelled as a continuous
response variable with the treatment assignment as
the explanatory variable across the repeated meas-
ures in each individual using a generalised estimating
equation approach (Diggle et al. 2002), according to
the following model, DWEIGHTij = b0 + b2EXPi +
bi + eij
Where E (bi) = E (eij) = 0, Var (bi) = sB2 and Var
(eij) = sW2, WEIGHTij is the weight measurements
during follow-up (j) for subject (i), EXPi is the treat-
ment assignment for subject (i), bi is the between-
person random error, eij is the within-individual
random error,sB2 is the between-person variance and
sW2 is the within-person variance. Robust estimators
of the variance were used to construct CI and
P-values in the analysis, and the working correlation
structure allowed for negative correlations between
successive pairs of measurements as would be
expected for a dependent variable of this form.
Models for the effect of multivitamin supplementa-
tion on total weight gain controlled for gestational
age at randomisation and time from the first weight
measurement to the last weight measurement.Trimes-
ter specific analyses were done using data in each
trimester. Only women having at least two weight
measurements in each trimester were included. For
the weight difference analysis, this means that inter-
vals beginning in the second trimester and ending in
the third trimester were excluded. The analysis of
weight gain as a mediator between multivitamin sup-
plementation and birthweight used the method of
Lin, Fleming and DeGruttola (Lin et al. 1997). We
also assessed whether the effect of supplements was
modified by baseline characteristics, including BMI at
entry to this study, haemoglobin (<11,  11 g dL-1),
cluster of differentiation 4 (CD4) count as a marker
of immune status with the median as the cut-off
(<775,  775 cells mm-3) and malaria infection
(malaria at baseline vs. no malaria), prematurity
(defined as birth before 37 weeks of gestation.), the
calendar months of the first and last measurements
and the number of weight measurements. Modifica-
tion of the effect of multivitamin supplementation on
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the total weight change was examined by adding the
interaction terms of multivitamin supplementation
with the potential modifier to a model with the main
effects and testing by the robust score test.
Birth outcomes in relation to rate of weight gain
The association between total weight gain and birth-
weight was analysed using regression models control-
ling for gestational age at first weight measurement,
time from first to last weight measurement, and time
from last weight measurement to delivery, as well as
the multivitamin group. The possibly non-linear rela-
tionship between weight gain and birthweight was
examined non-parametrically with restricted cubic
splines (Durrleman & Simon 1989) in a model
adjusted as described above.
To examine the relationship between gestational
weight gain and birthweight outcome, linear regres-
sion was used with birthweight as a continuous vari-
able and total weight gain categorised in quartiles.We
adjusted for multivitamins regimen, BMI at randomi-
sation, height, marital status, parity, number of weight
measurements, gestational age at delivery and fetal
sex.
We assessed whether the association between
pregnancy weight gain and the risk of low birth-
weight was modified by baseline BMI at entry to this
study. The statistical significance of this interaction
was tested using the likelihood ratio test. Tests for
non-linearity used the robust score test for the con-
tinuous birthweight outcome and the likelihood
ratio test for the dichotomised outcome, comparing
the model with only the linear term to the model
with both the linear and the cubic spline terms.
Analyses were carried out with Statistical Analyses
System software, Version 9 (SAS Institute Inc., Cary,
NC, USA).
Continuous variables are presented as mean (SD).
Estimates based on models are presented as estimate
(95% CI). Categorical variables are summarised as
per cents. Effects on binary outcomes are summarised
as RRs with 95% CI. All P-values are two-sided. A
P-value  0.05 is considered significant. No adjust-
ments were made for multiple comparisons.
Results
A total of 8468 HIV-negative women were ran-
domised, but only 7689 women with singleton preg-
nancies and at least two weight measurements during
pregnancy were included in the analysis. Of these,
7378 women had live births, and the 7354 with known
birthweights were included in the birthweight analy-
ses. The characteristics of our study population are
shown in Table 1. The distribution of baseline covari-
ates, including the socio-demographic characteristics,
did not differ significantly across treatment regimens.
The mean gestational age at randomisation was
21 weeks (SD: 3.5) and the last visit before delivery
occurred at 36 weeks (SD: 3.9) on average. The
average time from last weight measurement to deliv-
ery was 3 weeks (SD: 2.7), and this did not differ
Table 1. Maternal characteristics at baseline according to treatment
assignment*
Characteristic Placebo Multivitamin
Mean (SD) Mean (SD)
(n = 3935) (n = 3933)
Age (years) 25.1 (5.1) 25.2 (5.1)
Height (cm) 155.3 (7.5) 155.4 (8.0)
Weight (kg) 59.4 (10.6) 59.6 (10.5)
BMI (kg m-2) 24.6 (4.0) 24.6 (3.8)
MUAC (cm) 26.5 (4.3) 26.6 (4.0)
Education (years) 7.1 (2.8) 7.1 (2.9)
Parity 1.0 (1.3) 1.0 (1.3)
Wealth score† 1.6 (1.0) 1.6 (1.0)
Gestational age at recruitment
(weeks)
21.2 (3.5) 21.3 (3.5)
Gestational age at last weight
measurement (weeks)
36.3 (3.9) 36.4 (3.9)
CD4 count (cells mm-3) 804 (262) 807 (251)
Haemoglobin (g/100 mL) 10.3 (1.6) 10.2 (1.5)
Total energy intake (kcal) 2130 (866) 2129 (865)
Protein intake (g) 55 (34) 55 (33)
Carbohydrate intake (g) 351 (139) 351 (138)
Fat intake (g) 68 (42) 68 (43)
Time from randomisation to first
diet measurement (weeks)
7.6 (1.7) 7.6 (1.7)
Time from last weight
measurement to delivery
(weeks)
3.0 (2.7) 3.1 (2.9)
CD4, cluster of differentiation 4; MUAC, mid upper arm circumfer-
ence; SD, standard deviation. *None of the baseline characteristics
were significantly different between the treatment groups. †Filmer-
Pritchett wealth score.
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across the treatment regimens. There were 4.6 weight
measurements per woman, independent of treatment
assignment and 95% of the women had three or more
measurements.The women with  2 weight measure-
ments were comparable between the multivitamins
and the placebo groups with respect to baseline
characteristics.
The effects of multivitamins on weight gain are
shown in Table 2. Multivitamin supplementation
increased the overall total weight gain by 253 g (95%
CI: 177–388). The total weight gain from randomisa-
tion to the last visit during pregnancy was 5501 g (95%
CI, 5397–5605) in the multivitamin group, compared
to 5248 g (95% CI: 5150–5346) in the placebo group.
The overall 4-weekly weight gain in the multivitamins
group, 1379 g (95% CI: 1349–1408), was significantly
higher than that in the placebo group, 1319 (95% CI:
1291–1348). There was no difference in total weight
gain or 4-weekly weight gains between placebo and
multivitamin groups in the second trimester; however,
there was a significant difference between the placebo
and the supplementation groups in both the total
weight gain, 125 g (P = 0.001) and the 4-weekly weight
gains 70 g (P = 0.0008) in the third trimester.We found
no significant interactions between multivitamins and
baseline BMI (P > 0.10) Table 3.
There were 7378 women with live births. Of these,
7354 had infants with known birthweights. The rela-
tionship between total gestational weight gain and
birthweight was linear as shown in Fig. 1 (P = 0.001).
In the multivariate analysis, women in the lowest
quartile of gestational weight gain had babies with an
average birthweight of 3030 g (SD: 524),while women
in the highest quartile gain had babies weighing an
average of 3246 g (SD: 486). Baseline BMI did not
modify the relationship between gestational weight
gain and birthweight. Weight gain mediates 6.4%
(95% CI: 2.2, 10.7%) of the effect of multivitamin
supplementation on birthweight.
Discussion
We described the pattern of weight gain during preg-
nancy among HIV-negative women in Tanzania and
examined the relationship between the rates of
weight gain in pregnancy with birthweight. Multivita-
min supplementation resulted in increases in both
Table 2. Estimated total weight gain and weight gain by trimester for women in placebo and multivitamin arms*
Outcome N Placebo N Multivitamins Difference* (SE) P-value
Mean (SD) Mean (SD)
Estimated total weight gain (g)
Overall: from baseline to
last visit†
3749 5248 (5150, 5346) 3835 5501 (5397, 5605) 253 (177, 388) 0.0003
Second trimester 2758 1316 (1214, 1418) 2753 1400 (1304, 1496) 84 (-23, 191) 0.12
Third trimester 3407 2618 (2549, 2686) 3408 2743 (2671, 2814) 125 (30, 220) 0.001
Estimated 4 week weight gain (g)‡
Overall 3749 1319 (1291, 1348) 3735 1379 (1349, 1408) 59 (18, 100) 0.005
Second trimester 2758 1395 (1347, 1443) 2753 1447 (1399, 1496) 52 (-19, 123) 0.15
Third trimester 3407 1316 (1280, 1351) 3408 1385 (1348, 1422) 70 (18, 121) 0.008
SD, standard deviation. *Based on generalized estimating equations (GEE) models controlling for gestational age at first weight and the time
from to last weight measurement (estimated at the median values of the covariates for each time group). †From 21 to 36 weeks of gestation, on
average. ‡Based on GEE models controlling for time between measurements.
Table 3. Effects of multivitamin supplementation on gestational
weight gain stratified by body mass index (BMI) at baseline*
BMI category
(kg m-2)
N Effect
estimate† (kg)
P-value P for
interaction
<22 1890 0.17 0.17 0.41
22–<25 2391 0.22 0.07
25–29 2005 0.39 0.005
 30 656 0.23 0.39
*Baseline was 21 weeks of gestational age, on average. †Weight
gained by those in the multivitamin group – weight gained by those in
the placebo group based on generalized estimating equations (GEE)
models.
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overall total weight gain (253 g; 95%CI: 177–388) and
the 4-weekly weight gain (59 g; 95% CI: 18–100) in
pregnancy.There was a significant difference between
the placebo and the supplementation groups in both
the total weight gain and the 4-weekly weight gain in
the third trimester but not in the second trimester.
Taken together, these findings may suggest that the
effect of multivitamin supplements on gestational
weight gain may bemore pronounced during the third
trimester than the second trimester. If confirmed in
other studies, this may be reassuring as many women
in Tanzania and other developing countries do not
present to antenatal care, and hence be afforded the
benefit of micronutrient supplementation, until later
in the second trimester.
Multivitamins could improve the rate of weight
gain in pregnancy through various mechanisms
including improving the immune status that reduces
the risk of infections (Bendich 2001). Furthermore, by
restoring normal metabolism, multivitamins may
restore the feeling of well-being, which may result in
improved appetite (Committee on Nutrition 1958;
Major et al. 2008). Furthermore, multivitamins par-
ticularly thiamine and B vitamins have a role in
protein and energy metabolism, which could affect
fetal growth by improving the fetus’ handling of
macronutrients (Ashworth & Antipatis 2001), and
result in higher maternal weight gain during preg-
nancy.Another mechanism, through which multivita-
mins could improve fetal growth, is via the
antioxidant nature of vitamins such as C and E.There
are studies that have shown that maternal oxidative
stress plays an important role in the pathophysiology
of low birthweight (Scholl & Stein 2001). Micronutri-
ents might also improve birth outcomes by improving
placental development and function (Ashworth &
Antipatis 2001).
Our findings are in accord with other studies that
have examined the effect of multivitamin supplemen-
tation on the rate of weight gain during pregnancy.A
study that was conducted in a similar population in
Tanzania in HIV-positive women showed that multi-
vitamin supplementation resulted in an increase in
maternal weight gain during the third trimester
(304 g; 95% CI: 17, 590) and a significant 30% reduc-
tion in the risk of weight loss. A study in Greece
suggested that increases in serum vitamin C could
lead to a higher total weight gain (Kafatos et al. 1989).
In a supplementation trial in Chile which randomised
women received a milk-based product fortified with
thiamine, pyridoxine, niacin, vitamins A, C and E or a
non-fortified milk product, total weight gain was
significantly greater in the intervention group
(Mardones-Santander et al. 1988). Among women in
Mexico, however, multivitamin supplements did not
increase weight gain during pregnancy after adjusting
for baseline differences in BMI (Ramakrishnan et al.
2005).
We showed that an increase in rate of weight gain
during pregnancy increases birthweight; however, the
effect of the supplements on gestational weight gain
explained only about 6% of the effect on birthweight.
There are studies that have shown that low rate of
weight gain in pregnancy is associated with low birth-
weight (Abrams & Selvin 1995; Hickey et al. 1996;
Berenson et al. 1997). Some studies, however, have
shown that large gains in pregnancy weight are not
always beneficial in terms of improving birthweight
outcomes (Hickey et al. 1997; Nielsen et al. 2006).
Most of these studies documented excessive weight
gain to have adverse effects such as macrosomia with
a higher risk for birth injury (Johnson et al. 1992),
increased risk of operative delivery (Young &Wood-
mansee 2002) and increased risk for maternal mor-
bidity particularly postpartum weight retention
(Parker & Abrams 1993). In our study, the relation-
ship between gestational weight gain and birthweight
within the range of total weight gain of most of the
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Fig. 1. Birthweight in relation to total gestational weight gain.
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women in our study (0–15 kg) was linear.The associa-
tion of gestational weight gain and birthweight was
not modified by baseline BMI.
A strength of our study is that its large size gave
ample statistical power to examine the research ques-
tions of interest. One limitation, however, was that
women were largely enrolled in the middle of the
second trimester, which limited our ability to examine
at the effect of multivitamins in pregnancy from con-
ception through the first trimester and the ability to
study weight changes in the first trimester and early
second trimester.
In conclusion, multivitamin supplementation
during pregnancy increased gestational weight gain
among HIV-negative women in Tanzania. Birth-
weight increased with increased gestational weight
gain. Further research is required to find the optimal
weight gain in mothers in developing countries, and
the effects of intervening earlier in pregnancy on ges-
tational weight and on the risks of adverse pregnancy
outcomes.
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